Cerebrospinal fluid biomarkers, education, brain volume, and future cognition (scientific article)

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Q48499517

Head circumference and incident Alzheimer's disease: modification by apolipoprotein E.

Q48735427

Education modifies the association of amyloid but not tangles with cognitive function.

Q48766555

Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD.

Q48958887

CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study

Q50413832

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

Q51986028

Reliability of the Washington University Clinical Dementia Rating.

Q52126214

Validation of a short Orientation-Memory-Concentration Test of cognitive impairment.

Q52215816

A new clinical scale for the staging of dementia.

Q52220854

Parametric estimate of intensity inhomogeneities applied to MRI.

Q52923259

Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI

Q80071452

Cognitive Reserve and Alzheimer Disease

Q22242760

Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake

Q24646913

“Mini-mental state”

Q25938989

Education modifies the relation of AD pathology to level of cognitive function in older persons

Q28181517

Influence of education and occupation on the incidence of Alzheimer's disease

Q28251102

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

Q29028192

Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease

Q29540717

The Clinical Dementia Rating (CDR): current version and scoring rules

Q29616280

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

Q30755158

A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume

Q30970553

Cognitive reserve

Q33452282

Cerebrospinal fluid biomarkers of Alzheimer's disease

Q33757828

Autobiographical memory task in assessing dementia

Q33997516

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Q34098866

Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience

Q34429537

Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression

Q34461748

Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease

Q34585068

Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease

Q34646071

Brain reserve and the prevention of dementia

Q37125840

Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly

Q37391300

Interaction of neuritic plaques and education predicts dementia

Q37406173

Stability of the Clinical Dementia Rating, 1979-2007.

Q37425329

Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm

Q39512850

Global measures: utility in defining and measuring treatment response in dementia

Q40216161

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

Q40253365

P433

issue

P921

main subject

cerebrospinal fluid

Q54196

biomarker

Q864574

P304

page(s)

1145-1151

P577

publication date

2011-09-01

P1433

published in

Archives of Neurology

Q15766672

P1476

title

Cerebrospinal fluid biomarkers, education, brain volume, and future cognition

P478

volume

Reverse relations

cites work (P2860)

Q90719782	Cognitive Reserve from the Perspective of Preclinical Alzheimer Disease: 2020 Update
Q42858923	Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer's Disease in Cognitively Normal Individuals 10 Years Prior
Q30580439	Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span
Q36265279	Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease
Q50140579	Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease.
Q37520832	Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change
Q34600572	Internet-based screening for dementia risk
Q38681421	Life-course determinants of cognitive reserve (CR) in cognitive aging and dementia - a systematic literature review
Q92970068	Precision Aging: Applying Precision Medicine to the Field of Cognitive Aging
Q36813484	Preclinical Alzheimer disease-the challenges ahead
Q31063014	Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
Q37295601	Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease
Q35566575	Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease
Q34849048	The evolution of preclinical Alzheimer's disease: implications for prevention trials
Q40188198	Total Brain and Hippocampal Volumes and Cognition in Older American Indians: The Strong Heart Study
Q30845482	Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
Q34716695	Weighted brain networks in disease: centrality and entropy in human immunodeficiency virus and aging